|
KIAA1147 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63891122895166E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.19904086659517E-13 |
| Normal-vs-Stage2 |
1.322420E-03 |
| Normal-vs-Stage3 |
2.46391795855061E-12 |
| Normal-vs-Stage4 |
1.68542957368345E-12 |
| Stage1-vs-Stage2 |
5.292300E-02 |
| Stage1-vs-Stage3 |
2.111000E-01 |
| Stage1-vs-Stage4 |
1.027700E-02 |
| Stage2-vs-Stage3 |
7.744800E-03 |
| Stage2-vs-Stage4 |
1.299240E-03 |
| Stage3-vs-Stage4 |
2.231200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.76996261670138E-15 |
| Normal-vs-AfricanAmerican |
1.244830E-04 |
| Normal-vs-Asian |
1.06410436018223E-11 |
| Caucasian-vs-AfricanAmerican |
2.524800E-01 |
| Caucasian-vs-Asian |
5.936800E-01 |
| AfricanAmerican-vs-Asian |
1.849440E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.0378033422096E-11 |
| Normal-vs-Female |
1.67110769666579E-12 |
| Male-vs-Female |
8.496800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.33968400209505E-12 |
| Normal-vs-Age(41-60Yrs) |
7.56550377900567E-11 |
| Normal-vs-Age(61-80Yrs) |
5.85289594567939E-11 |
| Normal-vs-Age(81-100Yrs) |
6.197500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.878400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.600400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.818400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.712600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.098200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.721600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.14329999970175E-07 |
| Classical-VS-Follicular |
2.800200E-02 |
| Classical-VS-Other |
3.089200E-01 |
| Classical-VS-Normal |
1.64701585703142E-12 |
| Tall-VS-Follicular |
2.44740000487909E-08 |
| Tall-VS-Other |
4.556600E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.403810E-01 |
| Follicular-VS-Normal |
6.24900000000261E-05 |
| Other-VS-Normal |
1.981650E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.87159954201377E-10 |
| Normal-vs-N1 |
1.44217970898808E-12 |
| N0-vs-N1 |
2.110000E-02 |
|
|
